BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11855883)

  • 1. Reduced expression of early growth response-1 gene in leiomyoma as identified by mRNA differential display.
    Pambuccian CA; Oprea GM; Lakatua DJ
    Gynecol Oncol; 2002 Mar; 84(3):431-6. PubMed ID: 11855883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of early growth response-1 and its role in uterine leiomyoma growth.
    Shozu M; Murakami K; Segawa T; Kasai T; Ishikawa H; Shinohara K; Okada M; Inoue M
    Cancer Res; 2004 Jul; 64(13):4677-84. PubMed ID: 15231681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential gene expression in uterine leiomyoma.
    Skubitz KM; Skubitz AP
    J Lab Clin Med; 2003 May; 141(5):297-308. PubMed ID: 12761473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early growth response gene-1 plays a pivotal role in down-regulation of a cohort of genes in uterine leiomyoma.
    Ishikawa H; Shozu M; Okada M; Inukai M; Zhang B; Kato K; Kasai T; Inoue M
    J Mol Endocrinol; 2007 Nov; 39(5):333-41. PubMed ID: 17975260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines.
    Swartz CD; Afshari CA; Yu L; Hall KE; Dixon D
    Mol Hum Reprod; 2005 Jun; 11(6):441-50. PubMed ID: 15879465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of 14-3-3 gamma in uterine leiomyoma as identified by proteomics.
    Lv J; Zhu X; Dong K; Lin Y; Hu Y; Zhu C
    Fertil Steril; 2008 Nov; 90(5):1892-8. PubMed ID: 18054924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
    Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
    Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imprinting and expression status of isoforms 1 and 2 of PEG1/MEST gene in uterine leiomyoma.
    Moon YS; Park SK; Kim HT; Lee TS; Kim JH; Choi YS
    Gynecol Obstet Invest; 2010; 70(2):120-5. PubMed ID: 20339302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function.
    Hunter DS; Klotzbücher M; Kugoh H; Cai SL; Mullen JP; Manfioletti G; Fuhrman U; Walker CL
    Cancer Res; 2002 Jul; 62(13):3766-72. PubMed ID: 12097287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary study of genes related to uterine leiomyoma].
    Li T; Li XM; Yin HH; Yang YB
    Ai Zheng; 2004 Mar; 23(3):292-5. PubMed ID: 15025960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotensin and neurotensin receptor 1 expression in human myometrium and uterine leiomyomas.
    Rodríguez Y; Almeida TA; Valladares F; Báez D; Montes de Oca F; García C; Dorta I; Hernández M; Reyes R; Bello AR
    Biol Reprod; 2010 Oct; 83(4):641-7. PubMed ID: 20592307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical cadherin and catenin expression in normal myometrial tissues and uterine leiomyomas.
    Tai CT; Lin WC; Chang WC; Chiu TH; Chen GT
    Mol Reprod Dev; 2003 Feb; 64(2):172-8. PubMed ID: 12506349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray study of gene expression in uterine leiomyoma.
    Litovkin KV; Ivanova OV; Bauer A; Hoheisel JD; Bubnov VV; Zaporozhan VN
    Exp Oncol; 2008 Jun; 30(2):106-11. PubMed ID: 18566572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis.
    Hoffman PJ; Milliken DB; Gregg LC; Davis RR; Gregg JP
    Fertil Steril; 2004 Sep; 82(3):639-49. PubMed ID: 15374708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of several genes in human myometrium and uterine leiomyoma.
    Roth TM; Klett C; Cowan BD
    Fertil Steril; 2007 Mar; 87(3):635-41. PubMed ID: 17173903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of differentially expressed genes in human uterine leiomyomas using differential display.
    Li B; Sun M; He B; Yu J; Zhang YD; Zhang YL
    Cell Res; 2002 Mar; 12(1):39-45. PubMed ID: 11942409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
    Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
    Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression and tyrosine kinase activity of insulin receptor in uterine leiomyoma and matched myometrium.
    Toscani GK; Chaves EM; Cervi FL; Tavares MB; Silva IS; von Eye Corleta H; Capp E
    Arch Gynecol Obstet; 2004 Nov; 270(3):170-3. PubMed ID: 12937923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of early growth response-1 messenger ribonucleic acid in prostatic adenocarcinoma.
    Thigpen AE; Cala KM; Guileyardo JM; Molberg KH; McConnell JD; Russell DW
    J Urol; 1996 Mar; 155(3):975-81. PubMed ID: 8583621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma.
    Peng Y; Laser J; Shi G; Mittal K; Melamed J; Lee P; Wei JJ
    Mol Cancer Res; 2008 Apr; 6(4):663-73. PubMed ID: 18403645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.